ஒன்றுபட்டது கிஂக்டம் கட்டுப்பாட்டாளர்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Privacy Sandbox: Britische Regulatoren sollen die Entwicklung von Googles Cookie-Ersatz überwachen
derstandard.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from derstandard.at Daily Mail and Mail on Sunday newspapers.
Berichte: EU-Kartellprüfung auch gegen Facebook
euronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from euronews.com Daily Mail and Mail on Sunday newspapers.
Serum said- Rs 600 to private hospitals In the vaccine, 400 for states and the first like 150 for the center | सीरम ने कहा- प्राइवेट अस्पतालों को 250 की जगह 600 रु में मिलेगी वैक्सीन, राज्यों के लिए रेट 400 रु
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.
LHV Group plans to acquire a share in the financial company B-North
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators Extra Data Shows AstraZeneca Vaccine Efficacy In Elderly: UK Regulators Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December.
European countries have said more data is needed before it is given to those over 65.
London:
British regulators have received extra trial data from AstraZeneca that supports their view that the COVID-19 vaccine developed with Oxford University is effective in the elderly, a vaccines official said on Friday
Britain has been rolling out the shot among all age groups after the Medicines and Healthcare products Regulatory Agency (MHRA) was the first regulator to approve it in December, but some other European countries have said more data is needed before it is given to those over 65.